- King Pharma's $1.6B Offer Wins Over Alpharma (The Memphis Daily News)
NEW YORK (AP) - Alpharma Inc. has finally agreed to King Pharmaceuticals Inc.'s $1.6 billion cash takeover offer, ending the drugmakers' months-long b....
- Alpharma accepts higher bid from King Pharmaceuticals (Contra Costa Times)
Months of negotiations end with $1.6 billion cash takeover
- Ahead of the Bell: King Pharmaceuticals (AP via Yahoo! Finance)
Wall Street mainly applauded King Pharmaceuticals Inc.'s $1.6 billion cash takeover of Alpharma Inc. on Monday, saying it puts the combined company in a good position within the pain-treatment market.
- Business briefs: Nov. 26 (Knoxville News Sentinel)
Humana, one of the nation's largest publicly traded health and supplemental benefits companies, announced Tuesday that it has signed a multi-year sponsorship deal with Dollywood.
- Alpharma Accepts Takeover by King (TheStreet.com)
King pharmaceuticals raises its offer and Alpharma accepts, ending the months-long battle.
- Wall Street applauds King Pharma's Alpharma deal (Knoxville News Sentinel)
NEW YORK ? Wall Street mainly applauded Bristol, Tenn.-based King Pharmaceuticals Inc.?s $1.6 billion cash takeover of Alpharma Inc. on Monday, saying it puts the combined company in a good position within the pain-treatment market.
- King Pharma acquires Alpharma (CNN Money)
The drugmakers' months-long battle ends with a $1.6B cash takeover offer. NEW YORK (AP) -- Alpharma Inc. has finally agreed to King Pharmaceuticals Inc.'s $1.6 billion cash takeover offer, ending the drugmakers' months-long battle.
- Around the nation (Houston Chronicle)
- Alpharma accepts King's $1.6 billion bid (Belleville News-Democrat)
Alpharma Inc. has finally agreed to King Pharmaceuticals Inc.'s $1.6 billion cash takeover offer, ending the drugmakers' months-long battle.
- King Pharma to acquire Alpharma for about $1.6 billion (Reuters via Yahoo! News)
King Pharmaceuticals Inc said on Monday it has agreed to acquire Alpharma Inc for about $1.6 billion, ending a fractious takeover tussle and expanding King's presence in the market for pain drugs.